These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24042470)

  • 1. Telomerase regulation: a key to inhibition? (Review).
    Gómez DL; Farina HG; Gómez DE
    Int J Oncol; 2013 Nov; 43(5):1351-6. PubMed ID: 24042470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibition as cancer therapy.
    Saretzki G
    Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
    Kyo S; Inoue M
    Oncogene; 2002 Jan; 21(4):688-97. PubMed ID: 11850797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase modulation in therapeutic approach.
    Romaniuk A; Kopczynski P; Ksiazek K; Rubis B
    Curr Pharm Des; 2014; 20(41):6438-51. PubMed ID: 24975610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase: a potential therapeutic target for cancer.
    Fletcher TM
    Expert Opin Ther Targets; 2005 Jun; 9(3):457-69. PubMed ID: 15948667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of telomerase activity by apparently opposing elements.
    Liu JP; Chen SM; Cong YS; Nicholls C; Zhou SF; Tao ZZ; Li H
    Ageing Res Rev; 2010 Jul; 9(3):245-56. PubMed ID: 20362078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human telomerase expression regulation.
    Gladych M; Wojtyla A; Rubis B
    Biochem Cell Biol; 2011 Aug; 89(4):359-76. PubMed ID: 21790308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
    Philippi C; Loretz B; Schaefer UF; Lehr CM
    J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [siRNA targeting telomerase--effective tool in anti-cancer therapy?].
    Rubiś B; Półrolniczak A; Rybczyńska M
    Postepy Biochem; 2008; 54(4):384-92. PubMed ID: 19248585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by (Z)-stellettic acid C, an acetylenic acid from the sponge Stelletta sp., is associated with inhibition of telomerase activity in human leukemic U937 cells.
    Park C; Kim GY; Kim WI; Hong SH; Park DI; Kim ND; Bae SJ; Jung JH; Choi YH
    Chemotherapy; 2007; 53(3):160-8. PubMed ID: 17356266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma.
    Tang WK; Chui CH; Fatima S; Kok SH; Pak KC; Ou TM; Hui KS; Wong MM; Wong J; Law S; Tsao SW; Lam KY; Beh PS; Srivastava G; Ho KP; Chan AS; Tang JC
    Int J Mol Med; 2007 Jun; 19(6):953-60. PubMed ID: 17487429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
    Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
    [No Abstract]   [Full Text] [Related]  

  • 19. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
    Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
    Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
    Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A
    Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.